fluorouracil has been researched along with Carcinoma in Situ in 98 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with stage II/III breast cancer received four cycles of XT (capecitabine 1650 mg/m(2) on days 1-14 and docetaxel 60 mg/m(2) on day 8 every 3 weeks), followed by four cycles of FEC (5-fluorouracil 500 mg/m(2), epirubicin 90 mg/m(2), and cyclophosphamide 500 mg/m(2) on day 1 every 3 weeks)." | 9.14 | A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer. ( Hayashida, T; Ikeda, T; Jinno, H; Kitagawa, Y; Mukai, M; Sakata, M; Takahashi, M, 2010) |
"The clinical and pathologic response of carcinoma in situ of the vulva in a 42-year-old woman treated with topical 5-fluorouracil is reported." | 8.75 | Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva. ( Carson, TE; Hoskins, WJ; Wurzel, JF, 1976) |
"The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)." | 7.83 | Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016) |
"Topical therapeutic options for cutaneous squamous cell carcinoma in situ include 5-fluorouracil cream and imiquimod cream." | 7.73 | Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. ( Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD, 2006) |
"To assess safety, tolerance, and disease control of transurethral resection of the bladder tumor (TURB) plus concurrent cisplatin, 5-fluorouracil (5-FU), and radiation therapy (RT) with selective organ preservation in patients with bladder cancer." | 7.71 | Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. ( Dunst, J; Grabenbauer, GG; Kühn, R; Papadopoulos, T; Rödel, C; Sauer, R; Schrott, KM; Zörcher, T, 2002) |
"Local treatment with 5% of 5-Fluorouracil (5-Fu) in the form of globules was carried out on 37 patients with carcinoma in situ of the uterine cervix, established histologically, as the application was performed once daily for a period of 14-20 days." | 7.68 | [The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil]. ( Chakalova, G; Karag'ozov, A; Marinova, L; Ralcheva, Ts, 1991) |
"Topical 5-fluorouracil (5-FU) has been suggested as a simple and effective approach to the treatment of carcinoma in situ of the vulva." | 7.66 | Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil. ( Lifshitz, S; Roberts, JA, 1980) |
"A patient with vaginal carcinoma in situ was treated with 5-fluorouracil in a less intensive regimen that previously recorded." | 7.66 | A new regimen for the treatment of vaginal carcinoma in situ using 5-fluorouracil. Case report. ( Hawthorne, JH; Stokes, IM; Sworn, MJ, 1980) |
"Seven adult men with biopsy-confirmed erythroplasia of Queyrat (EQ) were cured of their disease with topically applied 5-fluorouracil (5-FU) under occlusion." | 7.65 | Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. ( Carson, TE; Goette, DK, 1976) |
"Anal cancer is an increasing issue in HIV-positive men who have sex with men (MSM)." | 6.78 | Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. ( de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ, 2013) |
"The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation." | 5.25 | Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975) |
"Patients with stage II/III breast cancer received four cycles of XT (capecitabine 1650 mg/m(2) on days 1-14 and docetaxel 60 mg/m(2) on day 8 every 3 weeks), followed by four cycles of FEC (5-fluorouracil 500 mg/m(2), epirubicin 90 mg/m(2), and cyclophosphamide 500 mg/m(2) on day 1 every 3 weeks)." | 5.14 | A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer. ( Hayashida, T; Ikeda, T; Jinno, H; Kitagawa, Y; Mukai, M; Sakata, M; Takahashi, M, 2010) |
"The clinical and pathologic response of carcinoma in situ of the vulva in a 42-year-old woman treated with topical 5-fluorouracil is reported." | 4.75 | Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva. ( Carson, TE; Hoskins, WJ; Wurzel, JF, 1976) |
"The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)." | 3.83 | Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016) |
"Topical therapeutic options for cutaneous squamous cell carcinoma in situ include 5-fluorouracil cream and imiquimod cream." | 3.73 | Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. ( Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD, 2006) |
"To assess safety, tolerance, and disease control of transurethral resection of the bladder tumor (TURB) plus concurrent cisplatin, 5-fluorouracil (5-FU), and radiation therapy (RT) with selective organ preservation in patients with bladder cancer." | 3.71 | Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. ( Dunst, J; Grabenbauer, GG; Kühn, R; Papadopoulos, T; Rödel, C; Sauer, R; Schrott, KM; Zörcher, T, 2002) |
"Local treatment with 5% of 5-Fluorouracil (5-Fu) in the form of globules was carried out on 37 patients with carcinoma in situ of the uterine cervix, established histologically, as the application was performed once daily for a period of 14-20 days." | 3.68 | [The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil]. ( Chakalova, G; Karag'ozov, A; Marinova, L; Ralcheva, Ts, 1991) |
"A patient with vaginal carcinoma in situ was treated with 5-fluorouracil in a less intensive regimen that previously recorded." | 3.66 | A new regimen for the treatment of vaginal carcinoma in situ using 5-fluorouracil. Case report. ( Hawthorne, JH; Stokes, IM; Sworn, MJ, 1980) |
" Adenocarcinoma related to diethylstilbestrol exposure in utero is a recently recognized type of vaginal lesion, and melanoma and sarcoma occur rarely in the vagina." | 3.66 | Malignant tumors of the vagina. Classification and approach to treatment. ( Gerbie, MV, 1983) |
"Topical 5-fluorouracil (5-FU) has been suggested as a simple and effective approach to the treatment of carcinoma in situ of the vulva." | 3.66 | Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil. ( Lifshitz, S; Roberts, JA, 1980) |
"Seven adult men with biopsy-confirmed erythroplasia of Queyrat (EQ) were cured of their disease with topically applied 5-fluorouracil (5-FU) under occlusion." | 3.65 | Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. ( Carson, TE; Goette, DK, 1976) |
"Overall accuracy of the residual cancer burden score determination was 0." | 2.80 | Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. ( Albarracin, C; Downs-Kelly, E; Gould, R; Hatzis, C; Morkowski, J; Peintinger, F; Sinn, B; Symmans, WF, 2015) |
"Anal cancer is an increasing issue in HIV-positive men who have sex with men (MSM)." | 2.78 | Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. ( de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ, 2013) |
"Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable." | 2.49 | Topical chemotherapy for ocular surface squamous neoplasia. ( Karp, CL; Nanji, AA; Sayyad, FE, 2013) |
"A case of extramammary Paget's disease of the scrotum is presented." | 2.38 | Paget's disease of the scrotum: a case report and review of current literature. ( Boman, DA; Dudrey, EF; Moliver, CL; Morales, CA; Reedy, MB, 1991) |
"Data on PeIN from the Swedish National Penile Cancer Register were analysed regarding treatment in relation to age, size of the PeIN lesion, localization of the PeIN lesion and complications using chi-squared tests and logistic regression." | 1.72 | Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019. ( Bjartling, C; Forslund, O; Kristiansen, S; Svensson, Å; Torbrand, C, 2022) |
" Fifty percent of patients reported Common Terminology Criteria for Adverse Events v5." | 1.62 | Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity. ( Aydin, AM; Chahoud, J; Cheryian, SK; Hajiran, A; Pow-Sang, JM; Spiess, PE; Zemp, L, 2021) |
"To review outcomes of the treatment of carcinoma in situ (CIS) of the penis at a large supra-regional penile cancer network, where centralisation has permitted greater experience with treatment outcomes, and suggest treatment strategies." | 1.42 | The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network. ( Jones, S; Lau, MW; Lucky, M; Murthy, KV; Parr, NJ; Rogers, B; Sangar, VK, 2015) |
"The use of topical agents in the treatment of carcinoma in situ (CIS) of the penis has been well described in the literature." | 1.38 | Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. ( Alnajjar, HM; Bolgeri, M; Lam, W; Perry, MJ; Rees, RW; Watkin, NA, 2012) |
" The most common side effect of this medication is localized irritant dermatitis." | 1.37 | Metallic taste as a side effect of topical fluorouracil use. ( Han, SY; Youker, S, 2011) |
"Capecitabine was administered at a median dose of 1600 mg/m2/day (range, 1200-1800 mg/m2)." | 1.33 | A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. ( Fontana, J; Forman, J; Frazier, A; Patel, B; Pontes, E; Vaishampayan, U, 2005) |
"In the majority of patients with rectal cancer invading perirectal tissues or lymph nodes, lesions downstages by preoperative chemo radiotherapy." | 1.32 | [Preoperative radiation with chemotherapy for rectal cancer: its impact on downstaging of disease and the role of endorectal ultrasound]. ( Juska, P; Pavalkis, D; Pranys, D, 2004) |
"To evaluate the efficacy of pulse dosing of topical 5-fluorouracil (5-FU) in the treatment of conjunctival and corneal intraepithelial neoplasia." | 1.31 | 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. ( Curry, CD; Engelbrecht, NE; Ford, JG; Walter, KA; Yeatts, RP, 2000) |
"Patients diagnosed with Chronic Lymphocytic Leukemia (CLL) have an increased risk of developing second primary cancers." | 1.31 | Multiple neoplasms: a case report. ( Pigeaud-Klessens, ML; van der Valk, P, 2002) |
"5-Fluorouracil showed to be an adequate treatment." | 1.29 | [Vaginal intraepithelial carcinoma. Diagnosis and management]. ( Chávez Brambilia, J; Deolarte Melgarejo, JM; González Sanchez, JL; Menéndez Velazquez, J, 1993) |
"A retrospective study of 56 patients treated for carcinoma in situ of the vulva over a 24-year period has shown a relative increase in the occurrence of this neoplasm." | 1.27 | Wide local excision in the treatment of vulvar carcinoma in situ: a reappraisal. ( Gallup, DG; Wolcott, HD, 1984) |
"The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation." | 1.25 | Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (40.82) | 18.7374 |
1990's | 12 (12.24) | 18.2507 |
2000's | 21 (21.43) | 29.6817 |
2010's | 21 (21.43) | 24.3611 |
2020's | 4 (4.08) | 2.80 |
Authors | Studies |
---|---|
Neale, H | 1 |
Michelon, M | 1 |
Jacob, S | 1 |
Pinkston, M | 1 |
Ukaegbu, R | 1 |
Zamor, W | 1 |
Morrison, E | 1 |
Deng, A | 1 |
Levin, NA | 1 |
Kristiansen, S | 1 |
Torbrand, C | 1 |
Svensson, Å | 1 |
Forslund, O | 1 |
Bjartling, C | 1 |
Hajiran, A | 1 |
Zemp, L | 1 |
Aydin, AM | 1 |
Cheryian, SK | 1 |
Pow-Sang, JM | 1 |
Chahoud, J | 1 |
Spiess, PE | 1 |
Stewart, JR | 1 |
Lang, ME | 1 |
Brewer, JD | 1 |
Tranoulis, A | 1 |
Georgiou, D | 1 |
Laios, A | 1 |
Theophilou, G | 1 |
Thangavelu, A | 1 |
Hutson, RC | 1 |
García de Oteyza, G | 1 |
Vázquez-Romo, KA | 1 |
Garcia-Vazquez, R | 1 |
Bermúdez-Cobos, D | 1 |
Ramos-Betancourt, N | 1 |
Richel, O | 1 |
de Vries, HJ | 1 |
van Noesel, CJ | 1 |
Dijkgraaf, MG | 1 |
Prins, JM | 1 |
Nanji, AA | 1 |
Sayyad, FE | 1 |
Karp, CL | 3 |
Bejarano, PA | 1 |
Boutros, M | 1 |
Berho, M | 1 |
Lucky, M | 1 |
Murthy, KV | 1 |
Rogers, B | 1 |
Jones, S | 1 |
Lau, MW | 1 |
Sangar, VK | 1 |
Parr, NJ | 1 |
Kenawy, N | 1 |
Garrick, A | 1 |
Heimann, H | 1 |
Coupland, SE | 1 |
Damato, BE | 1 |
Rashidi, A | 1 |
Amarillo, I | 1 |
Fisher, SI | 1 |
Peintinger, F | 1 |
Sinn, B | 1 |
Hatzis, C | 1 |
Albarracin, C | 1 |
Downs-Kelly, E | 1 |
Morkowski, J | 1 |
Gould, R | 1 |
Symmans, WF | 1 |
Jambusaria-Pahlajani, A | 1 |
Ortman, S | 1 |
Schmults, CD | 1 |
Liang, C | 1 |
Veloz-Martínez, MG | 1 |
Quintana-Romero, V | 1 |
Contreras-Morales, Mdel R | 1 |
Jiménez-Vieyra, CR | 1 |
Hsu, SH | 1 |
Gan, SD | 1 |
Nguyen, BT | 1 |
Konnikov, N | 1 |
Liang, CA | 1 |
Iovieno, A | 1 |
Lambiase, A | 1 |
Moretti, C | 1 |
Perrella, E | 1 |
Bonini, S | 1 |
Jinno, H | 1 |
Sakata, M | 1 |
Hayashida, T | 1 |
Takahashi, M | 1 |
Mukai, M | 1 |
Ikeda, T | 1 |
Kitagawa, Y | 1 |
Paczos, TA | 1 |
Ackers, S | 1 |
Odunsi, K | 1 |
Lele, S | 1 |
Mhawech-Fauceglia, P | 1 |
Terushkin, V | 1 |
Braga, JC | 1 |
Dusza, SW | 1 |
Scope, A | 1 |
Busam, K | 1 |
Marghoob, AA | 1 |
Gill, M | 1 |
Halpern, AC | 1 |
Ferreira, A | 1 |
Vieira, C | 1 |
Rodrigues, A | 1 |
Pereira, D | 1 |
Rodrigues, H | 1 |
Dávila, C | 1 |
Bento, S | 1 |
Shousha, MA | 1 |
Perez, VL | 1 |
Hoffmann, R | 1 |
Ventura, R | 1 |
Chang, V | 1 |
Dubovy, SR | 2 |
Wang, J | 1 |
Han, SY | 1 |
Youker, S | 1 |
Alnajjar, HM | 1 |
Lam, W | 1 |
Bolgeri, M | 1 |
Rees, RW | 1 |
Perry, MJ | 1 |
Watkin, NA | 1 |
Galor, A | 1 |
Oellers, P | 1 |
Kao, AA | 1 |
Abdelaziz, A | 1 |
Feuer, W | 1 |
Costello, E | 1 |
Greenhalf, W | 1 |
Neoptolemos, JP | 1 |
Schechter, BA | 2 |
Nagler, RS | 2 |
Snyder, ME | 1 |
Semiglazov, VF | 1 |
Maksimov, SIa | 1 |
Semiglazov, VV | 1 |
Kosnikov, AG | 1 |
Juska, P | 1 |
Pavalkis, D | 1 |
Pranys, D | 1 |
Murta, EF | 1 |
Neves Junior, MA | 1 |
Sempionato, LR | 1 |
Costa, MC | 1 |
Maluf, PJ | 1 |
Patel, B | 1 |
Forman, J | 1 |
Fontana, J | 1 |
Frazier, A | 1 |
Pontes, E | 1 |
Vaishampayan, U | 1 |
Downs, AM | 1 |
Geraghty, JM | 1 |
Jones, C | 1 |
Ondo, AL | 1 |
Mings, SM | 1 |
Pestak, RM | 1 |
Shanler, SD | 1 |
Tytherleigh, MG | 1 |
Birtle, AJ | 1 |
Cohen, CE | 1 |
Glynne-Jones, R | 1 |
Livingstone, J | 1 |
Gilbert, J | 1 |
Perrett, CM | 1 |
McGregor, JM | 1 |
Warwick, J | 1 |
Karran, P | 1 |
Leigh, IM | 1 |
Proby, CM | 1 |
Harwood, CA | 1 |
Weinberg, JM | 1 |
Soloway, MS | 1 |
Wolcott, HD | 1 |
Gallup, DG | 1 |
Seniukov, MV | 1 |
Goldobenko, GV | 1 |
Mardynskiĭ, IuS | 1 |
Lushnikov, EF | 1 |
Skoropad, IuD | 1 |
Gerbie, MV | 1 |
Petrilli, ES | 1 |
Townsend, DE | 2 |
Morrow, CP | 2 |
Nakao, CY | 1 |
Hofmann, W | 1 |
Langkopf, B | 1 |
Caglar, H | 3 |
Tamer, S | 1 |
Hreshchyshyn, MM | 3 |
Pride, GL | 1 |
Chuprevich, TW | 1 |
Foster, DC | 1 |
Woodruff, JD | 3 |
Sillman, FH | 2 |
Boyce, JG | 2 |
Macasaet, MA | 1 |
Nicastri, AD | 1 |
Hertzog, RW | 1 |
Daly, JW | 1 |
Ellis, GF | 1 |
Lifshitz, S | 1 |
Roberts, JA | 2 |
Stokes, IM | 1 |
Sworn, MJ | 1 |
Hawthorne, JH | 1 |
Hofmann, M | 1 |
Mahlke, M | 1 |
Casper, F | 1 |
Brockerhoff, P | 1 |
González Sanchez, JL | 1 |
Chávez Brambilia, J | 1 |
Menéndez Velazquez, J | 1 |
Deolarte Melgarejo, JM | 1 |
van Slooten, HJ | 1 |
Clahsen, PC | 1 |
van Dierendonck, JH | 1 |
Duval, C | 1 |
Pallud, C | 1 |
Mandard, AM | 1 |
Delobelle-Deroide, A | 1 |
van de Velde, CJ | 1 |
van de Vijver, MJ | 1 |
Kotoulas, IG | 2 |
Cardamakis, E | 2 |
Relakis, K | 2 |
Diamantis, A | 1 |
Papathanasiou, Z | 2 |
Korantzis, A | 2 |
Mantouvalos, C | 1 |
Yeatts, RP | 2 |
Ford, JG | 2 |
Stanton, CA | 1 |
Reed, JW | 1 |
Ginopoulos, P | 1 |
Metalinos, K | 1 |
Stathopoulos, E | 1 |
Michopoulos, J | 1 |
Mantouvalos, H | 1 |
Tzingounis, V | 1 |
Fowble, B | 1 |
Hanlon, AL | 1 |
Patchefsky, A | 1 |
Freedman, G | 1 |
Hoffman, JP | 1 |
Sigurdson, ER | 1 |
Goldstein, LJ | 1 |
Campagnutta, E | 1 |
Parin, A | 1 |
De Piero, G | 1 |
Giorda, G | 1 |
Gallo, A | 1 |
Scarabelli, C | 1 |
Engelbrecht, NE | 1 |
Curry, CD | 1 |
Walter, KA | 1 |
Pehoushek, J | 1 |
Smith, KJ | 1 |
Cardosi, RJ | 1 |
Bomalaski, JJ | 1 |
Hoffman, MS | 1 |
Burcombe, RJ | 1 |
Makris, A | 1 |
Pittam, M | 1 |
Lowe, J | 1 |
Emmott, J | 1 |
Wong, WL | 1 |
Yamamoto, N | 1 |
Ohmura, T | 1 |
Suzuki, H | 1 |
Shirasawa, H | 1 |
Rödel, C | 2 |
Grabenbauer, GG | 2 |
Kühn, R | 2 |
Dunst, J | 2 |
Papadopoulos, T | 2 |
Schrott, KM | 2 |
Sauer, R | 2 |
Zörcher, T | 1 |
Pigeaud-Klessens, ML | 1 |
van der Valk, P | 1 |
Habs, M | 1 |
Ang, J | 1 |
Schmähl, D | 1 |
Kaufman, RH | 1 |
Ballon, SC | 1 |
Lagasse, LD | 2 |
Krupp, PJ | 1 |
Bohm, JW | 1 |
Forney, JP | 1 |
DiSaia, PJ | 1 |
Goette, DK | 2 |
Carson, TE | 2 |
Hoskins, WJ | 1 |
Wurzel, JF | 1 |
Mansell, PW | 1 |
Litwin, MS | 3 |
Ichinose, H | 2 |
Krementz, ET | 2 |
Parmley, TH | 1 |
Julian, CG | 1 |
Cheson, BD | 2 |
Ungerleider, RS | 1 |
Grau, C | 1 |
Overgaard, J | 1 |
Reedy, MB | 1 |
Morales, CA | 1 |
Moliver, CL | 1 |
Dudrey, EF | 1 |
Boman, DA | 1 |
Chakalova, G | 1 |
Karag'ozov, A | 1 |
Marinova, L | 1 |
Ralcheva, Ts | 1 |
Abdennader, S | 1 |
Lessana-Leibowitch, M | 1 |
Pelisse, M | 1 |
Krebs, HB | 2 |
Sedlis, A | 1 |
Barten, G | 1 |
de Keizer, RJ | 1 |
de Wolff-Rouendaal, D | 1 |
van Delft, JL | 1 |
Bernstein, G | 1 |
Forgaard, DM | 1 |
Miller, JE | 1 |
Delgado, G | 1 |
Meyer, JS | 1 |
Lathrop, JC | 1 |
Ree, HJ | 1 |
McDuff, HC | 1 |
Weintraub, I | 1 |
Ryan, RF | 1 |
Reed, RR | 1 |
Kremetz, ET | 1 |
Dean, RE | 1 |
Taylor, ES | 1 |
Weisbrod, DM | 1 |
Martin, JW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Study of Pomalidomide in Anal Cancer Precursors (SPACE): a Phase 2 Study of Immunomodulation in People With Persistent HPV-associated High Grade Squamous Intraepithelial Lesions[NCT03113942] | Phase 2 | 26 participants (Actual) | Interventional | 2017-06-14 | Active, not recruiting | ||
Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860] | 560 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons[NCT02437851] | Phase 2 | 16 participants (Actual) | Interventional | 2015-04-30 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
12 reviews available for fluorouracil and Carcinoma in Situ
Article | Year |
---|---|
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2022 |
5-Flouorouracil Is an Attractive Medical Treatment in Women With Vaginal Intraepithelial Neoplasia: A Meta-Analysis.
Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Fluorouracil; Humans; Observational Studies as Top | 2018 |
Topical chemotherapy for ocular surface squamous neoplasia.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; | 2013 |
Anal squamous intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; A | 2013 |
New biomarkers and targets in pancreatic cancer and their application to treatment.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Pan | 2012 |
Topical therapy for actinic keratoses: current and evolving therapies.
Topics: Administration, Cutaneous; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinom | 2006 |
Diagnosis and management of vulvar and vaginal intraepithelial neoplasia.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Biopsy; Carcinoma in Situ; Female; Fluorou | 2001 |
Invasive bladder cancer: organ preservation by radiochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carbopla | 2002 |
Intraepithelial carcinoma of the vulva.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorouracil; Humans; | 1977 |
Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva.
Topics: Administration, Topical; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluorouracil; H | 1976 |
Paget's disease of the scrotum: a case report and review of current literature.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Genital Neopla | 1991 |
A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Anal Canal; Anus Neoplasms; Carc | 1985 |
10 trials available for fluorouracil and Carcinoma in Situ
Article | Year |
---|---|
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infec | 2013 |
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, | 2015 |
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma in | 2010 |
[The modern organ- and function-sparing surgical treatment in oncology].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carci | 2003 |
Fluorouracil does not improve the outcome of imiquimoid treatment of vulval intraepethelial neoplasia.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Therapy, | 2005 |
Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Bowen's Disease | 2007 |
Systemic therapy for superficial bladder cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Clinical Trials as Topic; Cyclophospha | 1984 |
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcino | 1996 |
Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU).
Topics: Administration, Topical; Adult; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Carc | 1997 |
Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina.
Topics: Administration, Intravaginal; Administration, Topical; Carcinoma in Situ; Combined Modality Therapy; | 1986 |
76 other studies available for fluorouracil and Carcinoma in Situ
Article | Year |
---|---|
Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorou | 2022 |
Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019.
Topics: Adult; Carcinoma in Situ; Fluorouracil; Humans; Imiquimod; Incidence; Male; Penile Neoplasms; Sweden | 2022 |
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous | 2021 |
Complete regression of a giant conjunctival intraepithelial neoplasia using 5-Fluorouracil.
Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neop | 2019 |
The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma in Situ; Circumcision, Male; Combin | 2015 |
Conjunctival squamous cell neoplasia: the Liverpool Ocular Oncology Centre experience.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Brachytherapy; Carcinoma in Situ; C | 2015 |
BRCA2-associated therapy-related acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Duct | 2015 |
Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
Topics: Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Ther | 2016 |
[Treatment results for different categories of vaginal intraepithelial neoplasia with electrocoagulation, 5-fluorouracil and combined treatment].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squam | 2015 |
Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinom | 2016 |
Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoma in Situ | 2009 |
Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy.
Topics: Adenocarcinoma; Biopsy; Carcinoma in Situ; DNA, Viral; Female; Fluorouracil; Histocytochemistry; Hum | 2010 |
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curet | 2010 |
Bevacizumab in the treatment of metastatic breast cancer: three case reports.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2011 |
Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
Topics: Administration, Topical; Aged; Aged, 80 and over; Biopsy; Carcinoma in Situ; Conjunctival Neoplasms; | 2011 |
Metallic taste as a side effect of topical fluorouracil use.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous C | 2011 |
Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Fluorour | 2012 |
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; | 2012 |
Successful treatment with 5-Fu.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Cor | 2003 |
Successful treatment with 5-Fu.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Cor | 2003 |
Conjunctival intraepithelial neoplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in | 2003 |
[Preoperative radiation with chemotherapy for rectal cancer: its impact on downstaging of disease and the role of endorectal ultrasound].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuvant; | 2004 |
Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Female; | 2005 |
A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma in Situ; Carcinoma | 2005 |
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Co | 2006 |
Combined surgery and chemoradiation as a treatment for the Buschke-Löwenstein tumour.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinom | 2006 |
Wide local excision in the treatment of vulvar carcinoma in situ: a reappraisal.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Follow-Up Studies; Hu | 1984 |
[Procedure and results of combined radiation and surgical treatment of laryngeal cancer patients].
Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality T | 1983 |
Malignant tumors of the vagina. Classification and approach to treatment.
Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Child; Diethylstilbe | 1983 |
Vaginal intraepithelial neoplasia: Biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser.
Topics: Adult; Aged; Carbon Dioxide; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluorouracil; Huma | 1980 |
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Co | 1982 |
Vulvar intraepithelial neoplasia.
Topics: Adolescent; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Immunosuppression Therapy; | 1982 |
Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina.
Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Uterine Cervical Dysplasia | 1982 |
The use of dinitrochlorobenzene in the treatment of vulvar carcinoma in situ.
Topics: Administration, Topical; Adult; Carcinoma in Situ; Dinitrochlorobenzene; Female; Fluorouracil; Human | 1981 |
5-fluorouracil/chemosurgery for intraepithelial neoplasia of the lower genital tract.
Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Methods; Mi | 1981 |
Topical 5-fluorouracil treatment of vaginal intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Drug Evaluation; Female; Fluorouracil; Huma | 1981 |
Carcinoma in situ of the vagina.
Topics: Carcinoma in Situ; Female; Fluorouracil; Humans; Vagina; Vaginal Neoplasms | 1981 |
Treatment of vaginal dysplasia and carcinoma in situ with topical 5-fluorouracil.
Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Neoplasms, Multiple Prima | 1980 |
Treatment of carcinoma in situ of the vulva with topical 5-fluorouracil.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; | 1980 |
A new regimen for the treatment of vaginal carcinoma in situ using 5-fluorouracil. Case report.
Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Vagina; Vagin | 1980 |
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma in Si | 1995 |
[Vaginal intraepithelial carcinoma. Diagnosis and management].
Topics: Adult; Carcinoma in Situ; Colposcopy; Combined Modality Therapy; Cryosurgery; Female; Fluorouracil; | 1993 |
Peoscopic diagnosis of flat condyloma and penile intraepithelial neoplasia. IV. Urethral reservoir.
Topics: Adolescent; Adult; Carcinoma in Situ; Condylomata Acuminata; Endothelium; Female; Fluorouracil; Huma | 1996 |
Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
Topics: Administration, Topical; Adult; Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma in Situ; Ch | 1995 |
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neopl | 1998 |
Treatment of vaginal intraepithelial neoplasia (VAIN) with the carbon dioxide laser.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; Evaluati | 1999 |
5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ | 2000 |
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; | 2001 |
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemothe | 2002 |
Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neopla | 2002 |
Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cisplati | 2002 |
Multiple neoplasms: a case report.
Topics: Aged; Antimetabolites, Antineoplastic; Blepharoplasty; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2002 |
Chemotherapy studies in autochthonous rat tumors. Forestomach and bladder cancer.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma in Situ; Doxorubicin; Drug Combinations; Female | 1977 |
Topical 5-fluorouracil in the treatment of intraepithelial neoplasia of the vagina.
Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local | 1979 |
5-fluorouracil topical treatment of in situ vulvar cancer. A preliminary report.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; | 1978 |
Management of carcinoma in situ of the vulva.
Topics: Adult; Aged; Carcinoma in Situ; Colposcopy; Female; Fluorouracil; Humans; Middle Aged; Vulva; Vulvar | 1977 |
Erythroplasia of Queyrat: treatment with topical 5-fluorouracil.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Erythroplasia; Fl | 1976 |
Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
Topics: Administration, Topical; Biopsy; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous; | 1975 |
Topical 5-fluorouracil in the treatment of vaginal carcinoma-in-situ.
Topics: Administration, Topical; Adult; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Vagina | 1975 |
Clinical trials referral resource. High priority trials--III. Breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carci | 1992 |
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; C | 1992 |
[The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil].
Topics: Administration, Topical; Adult; Biopsy; Carcinoma in Situ; Cervix Uteri; Colposcopy; Female; Fluorou | 1991 |
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; | 1989 |
An atypical case of penile carcinoma in situ associated with human papillomavirus DNA type 18.
Topics: Adult; Blotting, Southern; Carcinoma in Situ; DNA, Viral; Fluorouracil; Humans; Male; Papillomavirid | 1989 |
Treatment of vaginal intraepithelial neoplasia with laser and topical 5-fluorouracil.
Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Laser Therapy; Middle Aged; Vaginal Ne | 1989 |
[Local treatment of cervical intraepithelial neoplasia with a 5 percent fluorouracil ointment].
Topics: Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cervix Uteri; Condylomata Acuminata; Female; Fl | 1987 |
Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.
Topics: Aged; Carcinoma in Situ; Conjunctival Diseases; Corneal Diseases; Drug Administration Schedule; Eyel | 1986 |
Carcinoma in situ of the glans penis and distal urethra.
Topics: Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Humans; | 1986 |
Partial and total skinning vulvectomy in treatment of carcinoma in situ of the vulva.
Topics: Adolescent; Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recu | 1986 |
Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Cy | 1986 |
Intraepithelial neoplasia of the neovagina.
Topics: Adult; Carcinoma in Situ; Epithelium; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; | 1985 |
Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinom | 1974 |
Reversibility of vulvar atypia by DNCB-induced delayed hypersensitivity.
Topics: Adult; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Chlorine; Female; Fluorouracil; Humans; | 1973 |
Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquam | 1972 |
The treatment of premalignant and malignant lesions of the vulva.
Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluoroura | 1974 |
Erythroplasia of Queyrat.
Topics: Administration, Topical; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Ma | 1974 |